Pharmafile Logo
Pharmafocus logo
Advanced Search

pharmaceutical

Showing 15 posts of 792 posts found.

lonely-1822414_960_720

Mental health crisis as UK struggles with number of psychiatrists

September 11, 2017
Business Services, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical, psychiatry

Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists …

News
novartis_window

Melanoma treatment: Novartis posts success, Roche stumbles

September 11, 2017
Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical

In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …

News
astrazeneca_plaque

AstraZeneca’s Tagrisso beats standard of care in halting NSCLC

September 11, 2017
Research and Development, Sales and Marketing AstraZeneca, ESMO, NSCLC, Tagrisso, non-small cell cell cancer, pharma, pharmaceutical

AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in …

News
29863293981_33b910b458_z

Teva finally announces successful CEO appointment

September 11, 2017
Medical Communications, Sales and Marketing Lundbeck, Teva, biotech, drugs, pharma, pharmaceutical

Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the …

News
casebia_logo1_rgb

Casebia Therapeutics bolsters leadership by bringing in two new faces

September 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, CRISPR Therapeutics, Casebia Therapeutics, biotech, drugs, pharma, pharmaceutical

Casebia therapeutics, a joint venture between Bayer and CRISPR Therapeutics, has moved to strengthen its leadership team by bringing in …

Appointment
toothbrush

Aspirin may be a cost-effective alternative to fillings

September 8, 2017
Medical Communications, Research and Development aspirin, biotech, dentist, drugs, pharma, pharmaceutical, tooth decay

Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay. In …

News
bms

BMS’ Opdivo gets a potential first-line boost in kidney cancer

September 8, 2017
Medical Communications, Research and Development Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has announced results from a Phase 3 trial showing that patients treated with Opdivo alongside Yervoy in patients …

News
1280px-niagara_river

Antidepressants polluting rivers building up in brains of fish

September 7, 2017
Medical Communications antidepressants, biotech, drugs, pharma, pharmaceutical

A study of ecosystem of the Niagara River has discovered that antidepressants are building up in the brains of fish. …

News
tom-graney_portrait

Vertex Pharma bring in new CFO, shares rise

September 7, 2017
Ironwood Pharmaceuticals, Vertex pharmaceuticals, biotech, drugs, pharma, pharmaceutical

Vertex Pharmaceuticals announced the appointment of J&J veteran, Tom Graney, as Senior Vice President and Chief Financial Officer. Graney will …

Appointment
spotleukaemia

Spotting Leukaemia

September 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, leukaemia, pharma, pharmaceutical

Leukaemia is a household name, but how much do we really understand about it? Not enough, says Bethany Torr, Campaigns …

Feature

New ‘pen’ device identifies cancerous tissue in just ten seconds

September 7, 2017
Research and Development Cancer, University of Texas, digital, medicine, pharma, pharmaceutical, tumour

Scientists at the Baylor College of Medicine, University of Texas have developed a device which they claim can identify cancerous …

News
bms_4

BMS hit by clinical trial hold from FDA

September 7, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, immunotherapy, opdivo, pharma, pharmaceutical

The FDA has placed a partial hold on clinical trials involving Bristol-Myers Squibb’s immunotherapy treatment, Opdivo, when used in combination …

News
shutterstock_232245868

Amgen and AstraZeneca’s experimental drug cuts asthma exacerbations by up to 71%

September 7, 2017
Research and Development Amgen, AstraZeneca, MedImmune, asthma, pharma, pharmaceutical, tezepelumab

An anti-TSLP monoclonal antibody jointly developed by Amgen and AstraZeneca’s global biologics and research division, MedImmune, has met its primary …

News
merckwindowweb

MSD plays catch up with €464m deal for fledgling biotech

September 7, 2017
Sales and Marketing Bristol-Myers Squibb, MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD has announced that it will acquire Rigontec, a three-year old German biotech, in a deal worth an initial €115 …

News
astrazeneca-sign

AstraZeneca’s Brilinta protects against adverse cardiovascular events for up to 5 years, new data reveals

September 7, 2017
Research and Development AstraZeneca, Brilinta, cardiovascular, heart attack, pharma, pharmaceutical, ticagrelor, trial

AstraZeneca has revealed new data supporting the long-term use and efficacy of its cardiovascular drug Brilinta (ticagrelor), showing that the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025